phencyclidine

This page covers all phencyclidine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Lysosomal Pro-X carboxypeptidase, Sigma non-opioid intracellular receptor 1, Glutamate NMDA receptor; GRIN1/GRIN2A.

Targets

Lysosomal Pro-X carboxypeptidase, Sigma non-opioid intracellular receptor 1, Glutamate NMDA receptor; GRIN1/GRIN2A

Phase 2 pipeline (1)

• PHENCYCLIDINE · Neuroscience
  Phencyclidine blocks the action of glutamate at the NMDA receptor, disrupting normal neural communication.

Patent intelligence

• phencyclidine patent landscape — aggregated cliff calendar, attackable patents, originator estates